Demir, A. B. Et Al. 2021. Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.. Folia biologica , vol.67, no.1 , 1-9.

Demir, A. B., Aktas, S., Altun, Z. S., Ercetin, P., Aktas, T. C., & Olgun, N., (2021). Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.. Folia biologica , vol.67, no.1, 1-9.

Demir, A. Et Al. "Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.," Folia biologica , vol.67, no.1, 1-9, 2021

Demir, A. B. Et Al. "Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.." Folia biologica , vol.67, no.1, pp.1-9, 2021

Demir, A. B. Et Al. (2021) . "Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.." Folia biologica , vol.67, no.1, pp.1-9.

@article{article, author={A. B. Demir Et Al. }, title={Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.}, journal={Folia biologica}, year=2021, pages={1-9} }